RESTORING LIFE'S BLUEPRINT
Live / Applied — Non-final action mailed (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 04 May 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99802313
- Mark type
- Stylized text
- Filed
- 04 May 2026
- Attorney of record
- Jacqueline Lesser
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of rare genetic diseases; pharmaceutical preparations primarily comprising cells for treatment of rare diseases; pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases.
- Class 042 — Scientific and technological services: Medical and scientific research in the field of gene therapy; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use. Research and development of pharmaceuticals using gene editing
Owner
- Sangrail Biologics Inc., Philadelphia, PA, US
Prosecution history
- 09 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Sept 2026 — NON-FINAL ACTION E-MAILED
- 09 Sept 2026 — NON-FINAL ACTION WRITTEN
- 06 Sept 2026 — ASSIGNED TO EXAMINER
- 03 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 May 2026 — APPLICATION FILING RECEIPT MAILED
- 04 May 2026 — NEW APPLICATION ENTERED